期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

BDSF对白假丝酵母体外作用的研究 被引量：2

BDSF differently affects yeast and hyphae Candida albicans
下载PDF
导出
摘要 白假丝酵母(又称白念珠菌)是人体重要的条件致病真菌。在正常人体中,白假丝酵母是一种无害共生真菌;在免疫力低下人群中,白假丝酵母可引起假丝酵母病,轻者可导致黏膜感染,重者可发展为系统性疾病,甚至危及生命。白假丝酵母从酵母相至菌丝相的形态转变是极其重要的致病因素之一。BDSF是小分子短链脂肪酸,由Burkholderia cenoce pacia分泌产生。对酵母相白假丝酵母,在BDSF≥30μmol/L时因菌丝生长受强烈抑制,无法从酵母相向菌丝相转变。而对菌丝相白假丝酵母,当BDSF在30μmol/L和60μmol/L时,菌丝进一步生长并产生分支,但随菌丝分支生长,新生的分支菌丝不断转变为酵母相;当BDSF增加至120μmol/L时,菌丝生长和分支状况几乎完全受抑制。由此可见,BDSF不仅强烈抑制菌丝生长,还可促使新生的菌丝相向酵母相转化。 Candida albicans （C. albicans） is an important opportunistic pathogen. It is a harmless symbiotic fungus that inhabits various niches of healthy individuals. However, under immunocompromised conditions, C. albicans can cause candidiasis associated with mucosal infection and life-threatening systemic disease. BDSF is a Burkholderia cenocepacia-produced short-chain fatty acid with anti-fungal activity. When yeast form of C. albican was treated by BDSF, the yeast-to-hyphal transition was blocked at 30 μmol/L. Although the mycelia growth of hyphal form of C. albicans was not inhibited by BDSF at 30-60 μmol/L, the new-born branches of the mycelium were constantly changed into yeast form. The growth of hyphae was totally inhibited by BDSF at 120 μmol/L. The results suggested that both growth and differentiation of C. albicans may be regulated by BDSF.
作者 周阿峰 汪联辉 翁丽星
机构地区 复旦大学生命科学学院微生物学和微生物工程系 南京邮电大学信息材料与纳米技术研究院
出处 《微生物与感染》 2012年第1期44-49,共6页 Journal of Microbes and Infections
基金 国家自然科学基金(90813010)
关键词 BDSF 白假丝酵母 形态转变 酵母相 菌丝相 BDSF Candida albicans Morphological transition Yeast form Hyphal form
分类号 R379 [医药卫生—病原生物学]
  • 相关文献

参考文献15

  • 1Banerjee SN,Emori TG,Culver DH,Gaynes RP,Jarvis WR,Horan T,Edwards JR,Tolson J,Henderson T,Martone WJ.Secular trends in nosocomial primary bloodstream infections in the United States,1980-1989[J].Am J Med,1991,91(3B):86S-89S.
  • 2Edmond MB,Wallace SE,McClish DK,Pfaller MA,Jones RN,Wenzel RP.Nosocomial bloodstream infections in United States hospitals:a three-year analysis[J].Clin Infect Dis,1999,29(2):239-244.
  • 3Wenzel RP,Gennings C.Bloodstream infections due to Candida species in the intensive care unit:identifyingespecially high-risk patients to determine prevention strategies[J].Clin Infect Dis,2005,41(Suppl6):S389-S393.
  • 4Colombo AL,Nucci M,Park BJ,Nouér SA,ArthingtonSkaggs B,da Matta DA,Warnock D,Morgan J,Brazilian Network Candidemia Study.Epidemiology of candidemia in Brazil:a nationwide sentinel surveillance of candidemia in eleven medical centers[J].J Clin Microbiol,2006,44(8):2816-2823.
  • 5Samaranayake LP,Fidel PL,Naglik JR,Sweet SP,Teanpaisan R,Coogan MM,Blignaut E,Wanzala P.Fungal infections associated with HIV infection[J].Oral Dis,2002,8(Suppl2):151-160.
  • 6Patterson TF.Approaches to fungal diagnosis in transplantation[J].Transpl Infect Dis,1999,1(4):262-272.
  • 7Lo HJ,Khler JR,DiDomenico B,Loebenberg D,Cacciapuoti A,Fink GR.Nonfilamentous C.albicans mutants are avirulent[J].Cell,1997,90(5):939-949.
  • 8Boon C,Deng Y,Wang LH,He Y,Xu JL,Fan Y,Pan SQ,Zhang LH.A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition[J].ISME J,2008,2(1):27-36.
  • 9He YW,Wu J,Cha JS,Zhang LH.Rice bacterial blight pathogen Xanthomonas oryzae pv.oryzae produces multiple DSF-family signals in regulation of virulence factor production[J].BMC Micobiol,2010,10:187.
  • 10He YW,Boon C,Zhou L,Zhang LH.Co-regulation of Xanthomonas campestris virulence by quorum sensing and a novel two-component regulatory system RavS/RavR[J].Mol Microbiol,2009,71(6):1464-1476.

同被引文献19

  • 1Onyewu C, Blankenship JR, Del Poeta M, Heitman J. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei [J]. Antimicrob Agents Chemother, 2003, 47(3): 956-964.
  • 2Georgopapadakou NH. Antifungals: mechanism of action and resistance, established and novel drugs [J]. Curr Opin Microbiol, 1998, 1(5): 547-557.
  • 3Wroblewska MM, Swoboda-Kopec E, Rokosz A, Krawczyk E, Marchel H, Luczak M. Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles [J]. Int J Antimicrob Agents, 2002, 20(6): 472-475.
  • 4Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsaker T, Gaustad P; Norwegian Yeast Study Group. Candidemia in Norway (1991 to 2003): results from a nationwide study [J]. J Clin Microbiol, 2006, 44(6) : 1977- 1981.
  • 5Arendrup MC. Update on antifungal resistance in Aspergillus and Candida [J]. Clin Microbiol Infect, 2014, 20(Suppl 6) : 42-48.
  • 6Wang LH, He Y, Gao Y, Wu JE, Dong YH, He C, Wang SX, Weng LX, Xu JL, Tay L, Fang RX, Zhang LH. A bacterial cell-cell communication signal with cross-kingdom structural analogues [ J]. Mol Microbiol, 2004, 51 (3): 903-912.
  • 7Boon C, Deng Y, Wang LH, He Y, Xu JL, Fan Y, Pan SQ, Zhang LH. A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition [J]. ISME J, 2008, 2(1): 27-36.
  • 8Zhang Y, Cai C, Yang Y, Weng L, Wang L. Blocking of Candida albicans biofilm formation by cis-2-dodecenoic acid and trans-2-dodecenoic acid [J]. J Med Microbiol, 2011, 60 (Pt 11) : 1643-1650.
  • 9Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J, Hebart H, Schumacher U, Einsele H. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation [J]. FEBS Lett, 1997, 400(1) : 80-82.
  • 10Miyazaki H, Miyazaki Y, Geber A, Parkinson T, Hitchcock C, Falconer DJ, Ward DJ, Marsden K, Bennett JE. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata [J]. Antimicrob Agents Chemother, 1998, 42(7): 1695-1701.

引证文献2

二级引证文献5

微生物与感染
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部